S. Herrmann

发表

Landscape as designed by farming systems: a challenge for landscape agronomists in Europe

N. Silvestri, E. Bonari, D. Rizzo, 2007 .

IL-12 augments antigen-dependent proliferation of activated T lymphocytes.

M. Bertagnolli, S. Herrmann, B. Lin, 1992, Journal of immunology.

Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells.

H. Fujiwara, S. Herrmann, T. Hamaoka, 1995, International immunology.

IL-4-supported induction of cytolytic T lymphocytes requires IL-2 and IL-6.

M. Bertagnolli, S. Herrmann, Y. Takai, 1991, Cellular immunology.

Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens.

Ji Ming Wang, L. Kwak, W. Murphy, 2000, International immunology.

Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF

J. Ritz, R. Soiffer, S. Herrmann, 1992, The Journal of experimental medicine.

Lateral mobility of class I histocompatibility antigens in B lymphoblastoid cell membranes: modulation by cross-linking and effect of cell density

D. Golan, B. Bierer, S. Herrmann, 1987, The Journal of cell biology.

IL-12 protects bone marrow from and sensitizes intestinal tract to ionizing radiation.

F. Finkelman, R. Neta, S. Herrmann, 1994, Journal of immunology.

The cloning of CD70 and its identification as the ligand for CD27.

R. Kriz, K. Kelleher, S. Herrmann, 1994, Journal of immunology.

Combination of CCR5 and CXCR4 Inhibitors in Therapy of Human Immunodeficiency Virus Type 1 Infection: In Vitro Studies of Mixed Virus Infections

M. Hirsch, R. Offord, S. Herrmann, 2000, Journal of Virology.

The mechanism of antigen presentation by dendritic cells and splenic adherent cells in the induction of an allogeneic cytotoxic T-lymphocyte response to H-2Kk liposomes.

S. Herrmann, S. Burakoff, J. Greenstein, 1986, Cellular immunology.

Purification of murine MHC antigens by monoclonal antibody affinity chromatography.

S. Herrmann, M. Mescher, A. Turkewitz, 1983, Methods in Enzymology.

Lymphocyte recognition of H-2 antigen in liposomes.

S. Herrmann, M. Mescher, 1981, Journal of supramolecular structure and cellular biochemistry.

Molecular mechanisms underlying IFN-y-mediated tumor growth inhibition induced during tumor immunotherapy with rlL-12

S. Herrmann, X. Tai, T. Hamaoka, 2005 .

Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor

B. Bierer, S. Herrmann, S. Burakoff, 1988, The Journal of experimental medicine.

A monoclonal antibody to LFA‐3, the CD2 ligand, specifically immobilizes major histocompatibility complex proteins

D. Golan, B. Bierer, S. Herrmann, 1989, European journal of immunology.

Analysis of the two-signal requirement for precursor cytolytic T lymphocyte activation using H-2Kk in liposomes.

S. Herrmann, S. Burakoff, M. Mescher, 1982, Journal of immunology.

Direct evidence for binding of CD8 to HLA class I antigens

S. Ratnofsky, S. Herrmann, S. Burakoff, 1989, The Journal of experimental medicine.

HIV-gp120 can block CD4-class II MHC-mediated adhesion.

S. Herrmann, S. Burakoff, Y. Rosenstein, 1990, Journal of immunology.

Membrane-bound anti-CD3 monoclonal antibodies trigger cytolytic T-lymphocyte-mediated tumor lysis.

R. Wilson, S. Herrmann, S. Burakoff, 1988, Archives of surgery.

Cytolytic T lymphocyte recognition of subcellular antigen.

S. Balk, S. Herrmann, S. Burakoff, 1982, Advances in experimental medicine and biology.

Antigen-presenting cell function in induction of helper T cells for cytotoxic T-lymphocyte responses: evidence for antigen processing.

B. Benacerraf, S. Herrmann, S. Burakoff, 1981, Proceedings of the National Academy of Sciences of the United States of America.

A sequence of cellular and molecular events involved in IL12-induced tumour regression.

H. Fujiwara, S. Herrmann, T. Hamaoka, 1995, Research in immunology.

IL-7 supports the generation of cytotoxic T lymphocytes from thymocytes. Multiple lymphokines required for proliferation and cytotoxicity.

M. Bertagnolli, S. Herrmann, 1990, Journal of immunology.

Generation of targets for alloreactive CTL using purified H-2Kk in liposomes and polyethylene glycol.

M. Reed, S. Herrmann, 1986, Molecular immunology.

Systemic in vivo antitumor activity of interleukin-12 against both transplantable and primary tumor.

K. Ando, T. Yahata, S. Habu, 1995, Immunology letters.

Both IL‐2 and IL‐4 Synergize with IL‐12 to Induce a CTL Response, a Response Completely Blocked by TGF‐β

S. Herrmann, K. Abdi, 1996, Annals of the New York Academy of Sciences.

CTL generation in the presence of IL-4 is inhibited by free p40: evidence for early and late IL-12 function.

S. Herrmann, K. Abdi, 1997, Journal of immunology.

Evidence that rapamycin inhibits interleukin-12-induced proliferation of activated T lymphocytes.

M. Bertagnolli, R. Kirkman, S. Herrmann, 1994, Transplantation.

CTL adhesion and antigen recognition are discrete steps in the human CTL-target cell interaction.

S. Herrmann, S. Burakoff, S. Mentzer, 1987, Journal of immunology.

Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes.

H. Fujiwara, S. Herrmann, X. Tai, 1995, Cancer research.

CXCR-4 Desensitization Is Associated with Tissue Localization of Hemopoietic Progenitor Cells1

D. Scadden, T. Cheng, Hongmei Shen, 2001, The Journal of Immunology.

Progenitor Cells Tissue Localization of Hemopoietic CXCR4 Desensitization Is Associated with

D. Scadden, T. Cheng, Hongmei Shen, 2001 .

Phenotypic and functional characteristics of in vivo-induced interleukin-12-activated killer cells.

Kazuhito Watanabe, K. Watanabe, T. Yahata, 1995, Immunology letters.

The ability of Ia and H‐2Kk‐bearing membranes to replace the antigen‐presenting cell in an H‐2Kkallogeneic cytotoxic T cell response

S. Herrmann, S. Burakoff, J. Greenstein, 1985, European journal of immunology.

Cellular interactions in the generation of cytolytic T lymphocyte responses: role of Ia-positive splenic adherent cells in presentation in H-2 antigen.

B. Benacerraf, S. Herrmann, S. Burakoff, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Molecular mechanisms underlying IFN-γ-mediated tumor growth inhibition induced during tumor growth inhibition induced during tumor immunotherapy with rIL-12

H. Fujiwara, S. Herrmann, X. Tai, 1996 .

Molecular mechanisms underlying IFN-gamma-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12.

H. Fujiwara, S. Herrmann, X. Tai, 1996, International immunology.

Interaction of CD2 with its ligand, LFA-3, in human T cell proliferation.

B. Bierer, S. Herrmann, S. Burakoff, 1988, Journal of immunology.

Requirement for three distinct lymphokines for the induction of cytotoxic T lymphocytes from thymocytes.

S. Herrmann, S. Burakoff, J. Greenstein, 1986, Journal of immunology.

B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes.

S. Clark, S. Herrmann, S. Burakoff, 1988, Journal of immunology.

The role of CD18 in phorbol ester-induced human monocyte-mediated cytotoxicity.

D. Faller, S. Herrmann, S. Burakoff, 1988, Cellular immunology.

Efficacious immunomodulatory activity of the chemokine stromal cell-derived factor 1 (SDF-1): local secretion of SDF-1 at the tumor site serves as T-cell chemoattractant and mediates T-cell-dependent antitumor responses.

J. Leonard, R. Hawley, S. Herrmann, 2002, Blood.

Cellular interactions in the generation of cytolytic T lymphocyte responses Analysis of the helper T cell pathway

B. Benacerraf, S. Herrmann, S. Burakoff, 1981, European journal of immunology.

Direct evidence for a receptor-ligand interaction between the T-cell surface antigen CD2 and lymphocyte-function-associated antigen 3.

M. Reed, S. Herrmann, S. Burakoff, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Proteolytic modifications of the carboxyl-terminal region of H-2Kk.

S. Herrmann, M. Mescher, C. Chow, 1982, Journal of Biological Chemistry.

In Vitro Inhibition of HIV-1 by Met-Sdf-1β Alone or in Combination with Antiretroviral Drugs

M. Hirsch, T. Chou, O. Yang, 1999, Antiviral therapy.

Approaches to immunotherapy of cancer: characterization of lymphokines as second signals for cytotoxic T-cell generation.

M. Bertagnolli, T. Eberlein, S. Herrmann, 1991, Surgery.

Enhanced induction of very late antigen 4/lymphocyte function-associated antigen 1-dependent T-cell migration to tumor sites following administration of interleukin 12.

H. Fujiwara, S. Herrmann, T. Hamaoka, 1997, Cancer research.

Triton X-100 extraction of P815 tumor cells: evidence for a plasma membrane skeleton structure

J. Robinson, S. Herrmann, M. Mescher, 1985, The Journal of cell biology.

The requirements for antigen multivalency in class I antigen recognition and triggering of primed precursor cytolytic T lymphocytes.

S. Herrmann, M. Mescher, 1986, Journal of immunology.

Purification of the H-2Kk molecule of the murine major histocompatibility complex.

S. Herrmann, M. Mescher, 1979, The Journal of biological chemistry.

Secondary cytolytic T lymphocyte stimulation by purified H-2Kk in liposomes.

S. Herrmann, M. Mescher, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Protein kinase C required for cytotoxic T lymphocyte triggering.

S. Herrmann, S. Burakoff, T. Nishimura, 1987, Journal of immunology.

Effect of timing of lymphokine presentation on generation of cytotoxic T lymphocytes.

R. Wilson, S. Herrmann, S. Burakoff, 1989, Archives of surgery.

Inhibition of lymphokine-activated killer cell-mediated cytotoxicity by phorbol ester.

S. Herrmann, S. Burakoff, T. Nishimura, 1989, Journal of immunology.

Small molecules for small minds? The case for biologic pharmaceuticals

S. Projan, S. Herrmann, D. Gill, 2004, Expert opinion on biological therapy.

Characterization of peptide binding to the murine MHC class I H-2Kk molecule. Sequencing of the bound peptides and direct binding of synthetic peptides to isolated class I molecules.

E. Brown, R. Hewick, S. Herrmann, 1994, Journal of immunology.

Enhanced Inhibition of Human Immunodeficiency Virus Type 1 by Met-Stromal-Derived Factor 1β Correlates with Down-Modulation of CXCR4

B. Walker, O. Yang, M. Dziejman, 1999, Journal of Virology.

Characterization of antigen association with accessory cells: specific removal of processed antigens from the cell surface by phospholipases.

K. Rock, B. Benacerraf, S. Herrmann, 1987, Proceedings of the National Academy of Sciences of the United States of America.

The Application of IL‐12 to Cytokine Therapy and Gene Therapy for Tumors

Kazuhito Watanabe, I. Saiki, T. Yahata, 1996, Annals of the New York Academy of Sciences.